Roivant affiliate files Form 144 to sell 200,000 shares

Roivant Sciences Ltd. reported a Form 144 notice for the proposed sale of 200,000 common shares to be sold on 04/20/2026 (method: Options Exercise, grant date 04/20/2022).

Rhea-AI Filing Summary

Roivant Sciences Ltd. reported a Form 144 notice for the proposed sale of 200,000 common shares to be sold on 04/20/2026 (method: Options Exercise, grant date 04/20/2022). The filing also shows recent dispositions: 200,000 shares on 02/13/2026, 7,051 shares on 02/20/2026, and 200,000 shares on 04/20/2026, with proceeds listed for each transaction.

Insights

Corporate Finance

TL;DR: Affiliate filed a Form 144 showing multiple sales and a proposed 200,000-share resale tied to option exercises.

The filing lists a proposed sale of 200,000 common shares on 04/20/2026 via an Options Exercise (grant date 04/20/2022). Recent reported dispositions include sales on 02/13/2026, 02/20/2026, and 04/20/2026 with cash amounts recorded.

Cash-flow treatment and purchaser identities are not detailed in the excerpt; subsequent SEC filings or broker disclosures would show completion details and any impact on outstanding float.

Key Figures

Proposed sale: 200,000 shares Sale on 02/13/2026: 200,000 shares Sale on 02/20/2026: 7,051 shares +1 more

4 metrics

Proposed sale 200,000 shares to be sold on 04/20/2026 via Options Exercise (grant date 04/20/2022)

Sale on 02/13/2026 200,000 shares disposition recorded 02/13/2026, proceeds <money>$5,298,373.26</money>

Sale on 02/20/2026 7,051 shares disposition recorded 02/20/2026, proceeds <money>$191,434.65</money>

Sale on 04/20/2026 200,000 shares disposition recorded 04/20/2026, proceeds <money>$5,648,836.44</money>

Key Terms

Options Exercise, Form 144, Wire

3 terms

Options Exercise financial

"Options Exercise - Grant Date 04/20/2022"

Exercising an option is the act of using a contract that gives you the right to buy or sell a specific stock at a set price. For investors, the decision to exercise matters because it turns a paper right into an actual trade — it can create immediate profit or loss, change how many shares are outstanding (which can dilute ownership), affect cash the investor must pay or receive, and trigger tax consequences, much like deciding to redeem a coupon for a fixed-price purchase.

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Wire financial

"200000 | 04/20/2026 | Wire"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Roivant Sciences (ROIV) Form 144 report?

It reports a proposed sale of 200,000 common shares to be sold on 04/20/2026 via an Options Exercise (grant date 04/20/2022). The filing also lists earlier dispositions in February and April 2026.

How many shares were reportedly sold in recent transactions?

The excerpt shows reported dispositions of 200,000 shares on 02/13/2026, 7,051 shares on 02/20/2026, and 200,000 shares on 04/20/2026. Each entry includes a cash amount associated with the sale.

What sale method is listed for the 200,000-share offering?

The 200,000-share proposed sale on 04/20/2026 is listed as an Options Exercise with the original grant date of 04/20/2022, and the settlement method shown as Wire.

Are proceeds for the listed sales shown?

Yes; the excerpt includes cash figures for each reported sale, for example $5,298,373.26 for one 200,000-share entry and $5,648,836.44 for another 200,000-share entry, tied to the respective transaction dates.

Does this Form 144 confirm the sales completed?

Form 144 is a notice of proposed resale by affiliates; it does not alone confirm settlement. Completion and market reporting would appear in subsequent trade records or SEC filings showing finalized dispositions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/20/2026 - 04:17 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001801917
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Roivant Sciences Ltd.
SEC File Number	001-40782
Address of Issuer	7TH FLOOR, 50 BROADWAY LONDON UNITED KINGDOM SW1H 0DB
Phone	441-295-5950
Name of Person for Whose Account the Securities are To Be Sold	Venker Eric
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Rockefeller Financial LLC 45 Rockefeller Plaza Floor 5 New York NY 10111	200000	5917135.05	715701137	04/20/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Shares	04/20/2026	Options Exercise - Grant Date 04/20/2022	Roivant Sciences Ltd.			200000	04/20/2026	Wire

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Eric Venker c/o Roivant Sciences LTD 7th Floor, 50 Broadway London X0 SW1H0DB	Common	02/13/2026	200000	5298373.26
Eric Venker c/o Roivant Sciences LTD 7th Floor, 50 Broadway London X0 SW1H0DB	Common	02/20/2026	7051	191434.65
Eeric Venker c/o Roivant Sciences Ltd. 7th Floor, 50 Broadway London X0 SW1H0DB	Common Shares	04/20/2026	200000	5648836.44

144: Remarks and Signature

Remarks	The shares reported on this Form 144 will be sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 03/28/2025.
Date of Notice	04/20/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/28/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Heather Virgoe as a duly authorized representative of National Financial Services LLC, as attorney-in-fact for Eric Venker
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)